Mirum Pharmaceuticals (MIRM) Free Cash Flow (2019 - 2026)

Mirum Pharmaceuticals' Free Cash Flow history runs 8 years deep, the most recent figure standing at -$229.4 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 11359.89% year-over-year to -$229.4 million; the TTM figure through Mar 2026 stood at -$172.6 million (down 2092.81% YoY), while the FY2025 annual figure was $54.9 million, up 488.01% from the prior year.
• Free Cash Flow was -$229.4 million for Q1 2026 at Mirum Pharmaceuticals, down from $5.5 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $39.5 million in Q3 2025 to a low of -$229.4 million in Q1 2026.
• Historically, Free Cash Flow has averaged -$21.0 million across 5 years, with a median of -$16.6 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Free Cash Flow soared 938.5% in 2025, then slumped 11359.89% in 2026.
• A 5-year view of Free Cash Flow shows it stood at -$34.5 million in 2022, then surged by 51.85% to -$16.6 million in 2023, then jumped by 69.38% to -$5.1 million in 2024, then soared by 207.45% to $5.5 million in 2025, then plunged by 4296.58% to -$229.4 million in 2026.
• The last three Free Cash Flow figures came in at -$229.4 million (Q1 2026), $5.5 million (Q4 2025), and $39.5 million (Q3 2025), per Business Quant data.